Following the successful completion of the NHS national pilot in April 2025, the highly anticipated first results assessing CYP2C19 genetic testing to guide clopidogrel use in ischaemic stroke and TIA ...

An ultra-sensitive blood test that reflects brain damage after acute ischemic stroke - and also predicts functional outcome. This is a discovery that is expected to be of great significance in the ...

Mobile stroke units (MSUs) are ambulances with staff and a computed tomographic scanner that may enable faster treatment with tissue plasminogen activator (t-PA) than standard management by emergency ...

Objectives This study assessed whether a previously developed Monte Carlo simulation model can be reused for evaluating various strategies to minimise time-to-treatment in southwest Netherlands for ...

Consent is an important consideration if introducing testing. A patient expert highlighted that people who have had a stroke often have severe cognitive impairment, may have difficulty with their ...

A blood test conducted in a prehospital setting may rapidly distinguish between ischemic and hemorrhagic stroke, potentially facilitating more rapid, targeted treatment. The test measures the levels ...